4 completed, 1 withdrawn. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow beclomethasone dipropionate: new trials by email Literature Review of beclomethasone dipropionate trials Research Report on beclomethasone dipropionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Ibrutinib, ECG, PFT's - Chronic GVHD | Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2021-05-10 | 2026-01-23 |
| Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Completed | Fred Hutchinson Cancer Center | 140 | 2007-04-01 | 2021-02-03 |
| 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis R926112, Beclomethasone dipropionate - Rhinitis, Allergic, Seasonal | Phase 2 | Completed | Rigel Pharmaceuticals | 375 | 2005-07-01 | 2005-11-11 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon beclomethasone dipropionate - Breast Cancer, Chronic Myeloproliferative Disorders | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 2000-07-01 | 2010-04-02 | |
| Preventing Frequent Sinus Infections in HIV-Infected Patients Pseudoephedrine hydrochloride, Guaifenesin, Cefuroxime axetil - HIV Infections, Sinusitis | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-10-28 |
Blast Crisis (2) · Burkitt Lymphoma (2) · Graft vs Host Disease (2) · Hematologic Neoplasms (2) · Hodgkin Disease (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Accelerated Phase (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic-Phase (2) · Leukemia, Myelomonocytic, Chronic (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2)
Fred Hutchinson Cancer Center (2) · National Cancer Institute (NCI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Rigel Pharmaceuticals (1)
United States (4)
David Hockenbery, MD (1) · Eli Meltzer, M.D. (1) · Elliott Grossbard, M.D. (1) · Harold Nelson, M.D. (1) · J Zurlo (1) · JA McCutchan (1) · Paul Martin (1) · Steven Z Pavletic, M.D. (1)